Vericel (VCEL) Retained Earnings (2010 - 2026)
Vericel recorded quarterly Retained Earnings of -$382.6 million in Q1 2026, down 139227.27% quarter-over-quarter from $275000.0 in Q4 2025, and up 5.31% year-over-year from -$363.3 million in Q1 2025.
Vericel's Retained Earnings history runs 17 years deep, the most recent figure standing at -$382.6 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 5.31% year-over-year to -$382.6 million; the TTM figure through Mar 2026 stood at -$382.6 million (up 5.31% YoY), while the FY2025 annual figure was $275000.0, up 100.07% from the prior year.
- Retained Earnings came in at -$382.6 million for Q1 2026 at Vericel, down from $275000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $275000.0 in Q4 2025 to a low of -$416.2 million in Q3 2023.
- A 5-year average of -$260.7 million and a median of -$392.8 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings plunged 1764756.52% in 2022 and surged 167.03% in 2025, its largest moves.
- Vericel's Retained Earnings stood at -$978000.0 in 2022, then soared by 89.78% to -$100000.0 in 2023, then tumbled by 392715.0% to -$392.8 million in 2024, then surged by 100.07% to $275000.0 in 2025, then sank by 139227.27% to -$382.6 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$382.6 million, $275000.0, and $258000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | -382.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -382.60 Mn |
| Dec 31, 2025 | 275,000.00 |
| Sep 30, 2025 | 258,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | -404.06 Mn |
| Dec 31, 2024 | -392.82 Mn |
| Sep 30, 2024 | -412.60 Mn |
| Jun 30, 2024 | -273,000.00 |
| Mar 31, 2024 | -407.04 Mn |
| Dec 31, 2023 | -100,000.00 |
| Sep 30, 2023 | -416.20 Mn |
| Jun 30, 2023 | -412.51 Mn |
| Mar 31, 2023 | -407.50 Mn |
| Dec 31, 2022 | -978,000.00 |
| Sep 30, 2022 | -405.92 Mn |
| Jun 30, 2022 | -399.30 Mn |
| Mar 31, 2022 | -390.38 Mn |
| Dec 31, 2021 | -154,000.00 |
| Sep 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -382.89 Mn |
| Mar 31, 2021 | -379.10 Mn |
| Dec 31, 2020 | -375.82 Mn |
| Sep 30, 2020 | -388.04 Mn |
| Jun 30, 2020 | -391.70 Mn |
| Mar 31, 2020 | -383.38 Mn |
| Dec 31, 2019 | -378.68 Mn |
| Sep 30, 2019 | 29,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Dec 31, 2018 | -39,000.00 |
| Sep 30, 2018 | -374.26 Mn |
| Jun 30, 2018 | -373.19 Mn |
| Mar 31, 2018 | -368.54 Mn |
| Sep 30, 2017 | -361.16 Mn |
| Jun 30, 2017 | -355.76 Mn |
| Mar 31, 2017 | -353.37 Mn |
| Dec 31, 2016 | 190,000.00 |
| Sep 30, 2016 | -337.39 Mn |
| Jun 30, 2016 | -330.72 Mn |
| Mar 31, 2016 | -327.68 Mn |
| Sep 30, 2015 | -71,000.00 |
| Jun 30, 2015 | 314.70 Mn |
| Mar 31, 2015 | 312.55 Mn |
| Dec 31, 2014 | -71,000.00 |
| Sep 30, 2014 | -70,000.00 |
| Jun 30, 2014 | 298.40 Mn |
| Mar 31, 2014 | -293.76 Mn |
| Dec 31, 2013 | 287.77 Mn |
| Sep 30, 2013 | -284.80 Mn |
| Jun 30, 2013 | -287.01 Mn |
| Mar 31, 2013 | -282.12 Mn |
| Dec 31, 2012 | -275.32 Mn |
| Sep 30, 2012 | -267.41 Mn |
| Jun 30, 2012 | -260.16 Mn |
| Mar 31, 2012 | -251.59 Mn |
| Dec 31, 2011 | -241.85 Mn |
| Sep 30, 2011 | -239.06 Mn |
| Jun 30, 2011 | -237.13 Mn |
| Dec 31, 2010 | -222.18 Mn |